Acquired Hemophilia A
Conditions
Interventions
None listed
Sponsors
Takeda Pharmaceutical Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Physicians who belong to the following clinical departments Dermatology, emergency medicine, orthopedics, obstetrics & gynecology, oncology, general medicine, gastroenterology, urology, gastroenterology surgery, respiratory surgery, neurosurgery, rheumatology & collagen medicine, geriatrics, pediatrics, general internal medicine
Exclusion criteria
Exclusion criteria: 1. Physicians with less than two years of clinical experience at giving their consent (excluding residency) 2. Physicians working in facilities other than clinics, university hospitals, general hospitals, national and public hospitals at giving their consent 3. Physicians who are not treating either outpatients or inpatients at giving their consent 4. Physicians who require regal representatives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease awareness level of AHA as assessed by the following items -Rate of physicians knowledge for AHA as assessed by recognition of AHA's presence, examination experiences based on the symptoms of the disease and number of patients based on the demographic data (physicians; department they belong to, facility type they are working at, and academic affiliation they belong to) | — |
Secondary
| Measure | Time frame |
|---|---|
| -Rate of suspecting AHA when physicians encounter a patient with typical bleeding symptoms of AHA -Sources of AHA information, interest, experience of examination, diagnosis and treatment and referral to other clinical departments | — |
Countries
Japan
Contacts
Public ContactMadoka Go
Takeda Pharmaceutical Company Limited Japan Medical Office
Outcome results
None listed